دورية أكاديمية
Complementary and alternative medicine on cognitive defects and neuroinflammation after sepsis.
| العنوان: | Complementary and alternative medicine on cognitive defects and neuroinflammation after sepsis. |
|---|---|
| المؤلفون: | Zhenxuan LI; Department of Infectious Diseases, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.; 2 Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing 100010, China.; 3 Infection immunity laboratory, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.; 4 Clinical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China., Xuerui W; Department of Infectious Diseases, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.; 2 Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing 100010, China.; 3 Infection immunity laboratory, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.; 4 Clinical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China., Ulloa L; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA., Youssef A; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA., Yunjing B; Department of Infectious Diseases, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.; 2 Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing 100010, China.; 3 Infection immunity laboratory, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.; 4 Clinical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China., Xiaolong XU; Department of Infectious Diseases, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.; 2 Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing 100010, China.; 3 Infection immunity laboratory, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.; 4 Clinical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China., Qingquan L; Department of Infectious Diseases, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.; 2 Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing 100010, China.; 3 Infection immunity laboratory, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.; 4 Clinical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. |
| المصدر: | Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan [J Tradit Chin Med] 2024 Apr; Vol. 44 (2), pp. 408-416. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Academy Of Traditional Chinese Medicine Country of Publication: China NLM ID: 8211546 Publication Model: Print Cited Medium: Internet ISSN: 2589-451X (Electronic) Linking ISSN: 02552922 NLM ISO Abbreviation: J Tradit Chin Med Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Beijing : Academy Of Traditional Chinese Medicine Original Publication: [Beijing, China : Pub. Office, Journal of Traditional Chinese Medicine, 1981- |
| مواضيع طبية MeSH: | Sepsis*/complications , Sepsis*/therapy , Cognitive Dysfunction*/etiology , Cognitive Dysfunction*/therapy , Complementary Therapies*, Animals ; Neuroinflammatory Diseases ; Cognition |
| مستخلص: | Sepsis-associated encephalopathy (SAE) is a common manifestation of sepsis, ranging from mild confusion and delirium to severe cognitive impairment and deep coma. SAE is associated with higher mortality and long-term outcomes, particularly substantial declines in cognitive function. The mechanisms of SAE probably include neuroinflammation that is mediated by systemic inflammation and ischemic lesions in the brain, a disrupted blood-brain barrier, oxidative stress, neurotransmitter dysfunction, and severe microglial activation. Increasing evidence suggests that complementary and alternative medicine, especially Traditional Chinese Medicine (TCM), is favorable in alleviating cognitive decline after sepsis. Here, we summarized the studies of traditional herbal remedies, TCM formulas and acupuncture therapy in animal models of neurological dysfunctions after sepsis in recent decades and reviewed their potential mechanisms. |
| References: | Brain Inj. 2009 Dec;23(13-14):1089-94. (PMID: 19891535) J Agric Food Chem. 2018 Jan 10;66(1):265-271. (PMID: 29237268) J Pharmacol Sci. 2016 Oct;132(2):138-144. (PMID: 27733273) J Ethnopharmacol. 2021 Jun 28;274:114046. (PMID: 33753146) Phytother Res. 2021 Jan;35(1):404-414. (PMID: 33044778) Molecules. 2019 Mar 01;24(5):. (PMID: 30823679) Behav Brain Res. 2020 Apr 6;383:112509. (PMID: 31987933) Nat Rev Dis Primers. 2016 Jun 30;2:16045. (PMID: 28117397) Int Immunopharmacol. 2020 Apr;81:106359. (PMID: 32143148) Epilepsy Res. 2017 Sep;135:176-186. (PMID: 28797776) Oncotarget. 2016 Aug 30;7(35):56045-56059. (PMID: 27517628) Sci Rep. 2017 Jan 06;7:40035. (PMID: 28059131) J Ethnopharmacol. 2020 Jun 28;256:112706. (PMID: 32109547) Expert Rev Anti Infect Ther. 2021 Feb;19(2):215-231. (PMID: 32808580) Mol Neurobiol. 2019 Jan;56(1):763-767. (PMID: 29876882) Radiology. 1986 Nov;161(2):401-7. (PMID: 3763909) Intensive Care Med. 2009 Nov;35(11):1886-92. (PMID: 19588122) Int J Pharm. 2021 Jun 15;603:120670. (PMID: 33964337) J Comput Biol. 2020 Jun;27(6):904-913. (PMID: 31573330) Biochimie. 2008 Oct;90(10):1566-77. (PMID: 18634844) Life Sci. 2018 Aug 1;206:45-60. (PMID: 29792878) Auton Neurosci. 2000 Dec 20;85(1-3):60-5. (PMID: 11189027) JAMA. 2016 Feb 23;315(8):801-10. (PMID: 26903338) Pharmacol Ther. 2008 Jan;117(1):30-51. (PMID: 17949819) Neurobiol Aging. 2014 Jun;35(6):1243-51. (PMID: 24368090) Neural Plast. 2019 Nov 11;2019:1571392. (PMID: 31814820) Acta Pharm Sin B. 2020 Jan;10(1):33-41. (PMID: 31993305) Cytokine. 2018 Oct;110:78-86. (PMID: 29705395) Neurosci Lett. 2019 Sep 14;709:134386. (PMID: 31330225) J Cent Nerv Syst Dis. 2019 Apr 09;11:1179573519840652. (PMID: 31007531) Geroscience. 2019 Aug;41(4):467-481. (PMID: 31473912) J Surg Res. 2017 Jan;207:181-189. (PMID: 27979475) Antioxidants (Basel). 2017 Apr 05;6(2):. (PMID: 28379197) Nutrients. 2020 Jul 07;12(7):. (PMID: 32645984) Nature. 2013 Jan 31;493(7434):674-8. (PMID: 23254930) Sci Rep. 2016 May 05;6:25457. (PMID: 27149601) J Psychopharmacol. 2021 Oct;35(10):1285-1299. (PMID: 34281416) Curr Opin Crit Care. 2012 Oct;18(5):518-26. (PMID: 22941208) Oxid Med Cell Longev. 2020 Sep 22;2020:4751349. (PMID: 33029280) Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2564-2573. (PMID: 28115287) Neuroscientist. 2019 Jun;25(3):227-240. (PMID: 29931997) Oncogene. 1999 Nov 22;18(49):6853-66. (PMID: 10602461) Pharm Biol. 2022 Dec;60(1):825-839. (PMID: 35587259) Braz J Med Biol Res. 2007 Jun;40(6):831-7. (PMID: 17581683) J Biol Chem. 2018 Jan 5;293(1):226-244. (PMID: 29127203) Behav Brain Res. 2016 Jan 15;297:112-5. (PMID: 26455875) Am J Physiol. 1993 Apr;264(4 Pt 1):C894-905. (PMID: 8476021) J Surg Res. 2020 Dec;256:258-266. (PMID: 32712439) Neurosci Lett. 2022 Jun 21;782:136697. (PMID: 35642797) Eur J Pharmacol. 2020 Aug 15;881:173297. (PMID: 32580037) Curr Neuropharmacol. 2009 Dec;7(4):296-301. (PMID: 20514209) Crit Care. 2013 Sep 18;17(5):R204. (PMID: 24047502) Biomed Pharmacother. 2018 Nov;107:1523-1529. (PMID: 30257370) Toxicol Appl Pharmacol. 2020 Dec 1;408:115261. (PMID: 33010263) Inflammation. 2017 Apr;40(2):387-400. (PMID: 27913953) Clin Physiol Funct Imaging. 2016 Nov;36(6):490-496. (PMID: 26017052) Brain Behav Immun. 2015 Jan;43:54-9. (PMID: 25019583) Mol Neurobiol. 2019 Jan;56(1):186-251. (PMID: 29687346) Nat Rev Neurol. 2013 Oct;9(10):551-61. (PMID: 23999468) Psychiatry Res. 2016 Jun 30;240:131-136. (PMID: 27107388) J Food Biochem. 2021 May;45(5):e13722. (PMID: 33855723) Mol Psychiatry. 2007 Jul;12(7):656-70. (PMID: 17264839) J Alzheimers Dis. 2013;33(1):29-33. (PMID: 22886025) Radiology. 2016 Jan;278(1):13-32. (PMID: 26690990) Neurotox Res. 2021 Apr;39(2):489-503. (PMID: 32876918) Crit Care. 2021 Jul 6;25(1):236. (PMID: 34229735) Int Immunopharmacol. 2020 Nov;88:106943. (PMID: 33182053) Int Immunopharmacol. 2018 Jan;54:311-319. (PMID: 29190543) Biomed Pharmacother. 2019 Mar;111:209-223. (PMID: 30583228) Neurotox Res. 2021 Dec;39(6):1800-1811. (PMID: 34655374) N Engl J Med. 2014 Jan 9;370(2):185-6. (PMID: 24401069) Front Cell Neurosci. 2018 Aug 08;12:255. (PMID: 30135647) Life Sci. 2019 Sep 1;232:116647. (PMID: 31301416) Front Pharmacol. 2020 May 08;11:579. (PMID: 32457609) J Agric Food Chem. 2017 Aug 16;65(32):6861-6869. (PMID: 28762741) Mol Med. 2021 May 5;27(1):45. (PMID: 33952191) Chin Med J (Engl). 2014;127(5):924-8. (PMID: 24571889) Food Funct. 2019 Sep 1;10(9):5827-5842. (PMID: 31463498) Brain Behav Immun. 2021 Oct;97:455. (PMID: 34412941) Eur J Pharmacol. 2015 Dec 5;768:49-57. (PMID: 26485503) Neurotox Res. 2010 Apr;17(3):279-86. (PMID: 19705213) Crit Care Med. 2007 Sep;35(9):2186-90. (PMID: 17855835) Crit Care. 2017 Oct 23;21(1):262. (PMID: 29058589) Neurosci Lett. 2018 Sep 14;683:190-195. (PMID: 29885447) Phytomedicine. 2020 Dec;79:153348. (PMID: 33039720) Brain Behav Immun. 2021 Jan;91:296-314. (PMID: 33039659) Psychiatry Res. 2016 Apr 30;238:116-121. (PMID: 27086220) Food Funct. 2019 Sep 1;10(9):6062-6073. (PMID: 31486445) J Neuroimmunol. 2019 Nov 15;336:577029. (PMID: 31487612) Lancet. 2010 Feb 27;375(9716):773-5. (PMID: 20189029) Brain Res Bull. 2021 May;170:65-73. (PMID: 33561536) J Magn Reson Imaging. 2020 Jun;51(6):1836-1843. (PMID: 31785074) J Food Biochem. 2021 Apr;45(4):e13660. (PMID: 33624846) Brain Res Bull. 2018 Sep;142:352-359. (PMID: 30179677) Sci Rep. 2016 Mar 09;6:22747. (PMID: 26956613) Behav Brain Res. 2014 Nov 1;274:282-90. (PMID: 25131506) Lancet. 2020 Jan 18;395(10219):200-211. (PMID: 31954465) Metab Brain Dis. 2017 Apr;32(2):415-426. (PMID: 27796565) CNS Neurosci Ther. 2022 Feb;28(2):247-258. (PMID: 34837343) Acta Physiol Hung. 2006 Dec;93(4):315-23. (PMID: 17191663) Oxid Med Cell Longev. 2021 Feb 15;2021:6647258. (PMID: 33628372) Intensive Care Med. 2021 Oct;47(10):1089-1103. (PMID: 34401939) Eur J Pharmacol. 2014 Dec 5;744:124-31. (PMID: 25446914) Biochem Biophys Res Commun. 2020 Oct 1;530(4):658-664. (PMID: 32768191) Brain Behav Immun. 2010 Nov;24(8):1223-8. (PMID: 20674737) Mol Neurobiol. 2021 Jun;58(6):2770-2779. (PMID: 33495934) J Neuroinflammation. 2022 Apr 29;19(1):101. (PMID: 35488237) Front Cell Dev Biol. 2019 Jun 20;7:108. (PMID: 31281814) Int Immunopharmacol. 2020 Mar;80:106181. (PMID: 31926446) J Ethnopharmacol. 2015 Apr 2;163:83-7. (PMID: 25625350) Nat Commun. 2016 Oct 25;7:13129. (PMID: 27779191) Neurosci Lett. 2021 Nov 20;765:136284. (PMID: 34624394) Int Immunopharmacol. 2020 Apr;81:106287. (PMID: 32058932) J Surg Res. 1996 Mar;61(2):496-502. (PMID: 8656632) Brain Res. 2020 Jun 15;1737:146780. (PMID: 32205148) Brain Res. 2018 Mar 01;1682:54-60. (PMID: 29317289) Exp Mol Pathol. 2014 Dec;97(3):386-92. (PMID: 25220346) Oxid Med Cell Longev. 2022 Aug 24;2022:1328729. (PMID: 36062193) Mol Neurobiol. 2019 Nov;56(11):7296-7304. (PMID: 31020614) Am J Chin Med. 2020;48(3):559-577. (PMID: 32345030) ACS Chem Neurosci. 2021 Sep 15;12(18):3387-3396. (PMID: 34469122) Immunol Rev. 2012 Sep;249(1):158-75. (PMID: 22889221) Circ Res. 2010 Dec 10;107(12):1498-502. (PMID: 21127294) J Ethnopharmacol. 2022 Feb 10;284:114766. (PMID: 34688798) Brain Res Bull. 2016 Oct;127:248-259. (PMID: 27771396) Mol Psychiatry. 2009 May;14(5):511-22. (PMID: 18195714) Metab Brain Dis. 2022 Aug;37(6):2039-2052. (PMID: 35731324) J Neuroinflammation. 2015 Nov 25;12:223. (PMID: 26608623) Biochem Biophys Res Commun. 2015 Jan 2;456(1):190-6. (PMID: 25446122) Acta Pharmacol Sin. 2021 Jul;42(7):1069-1079. (PMID: 33758353) Physiol Behav. 2022 Jan 1;243:113646. (PMID: 34780728) Int Immunopharmacol. 2018 Mar;56:29-35. (PMID: 29328946) Neuropediatrics. 2009 Apr;40(2):66-72. (PMID: 19809934) J Ethnopharmacol. 2022 Jan 10;282:114655. (PMID: 34537284) Pharmacology. 2022;107(5-6):281-289. (PMID: 35325888) J Neuroimmunol. 2011 Jan;230(1-2):48-51. (PMID: 20864183) Inflammopharmacology. 2019 Aug;27(4):809-816. (PMID: 29943151) |
| معلومات مُعتمدة: | 82004292 Youth Project of National Natural Science Foundation of China: the Mechanism Study of Shenfuhuang Formula on Cognitive Impairment and Synaptic Plasticity in Sepsis via IL-33/ST2 Pathway-mediated Microglial Polarization; 82141202 Special Project of National Natural Science Foundation of China: Study on the Mechanism and Material Basis of Jinhua Qinggan Granules in Regulating the Cytokine Storm of Viral Pneumonia; ZYYCXTD-D-202201 The National Interdisciplinary Innovation Team of TCM under the State Administration of TCM |
| فهرسة مساهمة: | Keywords: cognitive dysfunction; complementary therapies; medicine, Chinese traditional; neuroinflammatory diseases; review; sepsis-associated encephalopathy |
| تواريخ الأحداث: | Date Created: 20240320 Date Completed: 20240321 Latest Revision: 20240416 |
| رمز التحديث: | 20240416 |
| مُعرف محوري في PubMed: | PMC10927414 |
| DOI: | 10.19852/j.cnki.jtcm.20240203.002 |
| PMID: | 38504548 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2589-451X |
|---|---|
| DOI: | 10.19852/j.cnki.jtcm.20240203.002 |